Related Experiment Video

Updated: Aug 17, 2025

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

8.2K

Headache research in 2022: advances and remaining challenges

Uwe Reuter1

  • 1Department of Neurology, Charité Universitätsmedizin Berlin, Berlin 10117, Germany; Universitätsmedizin Greifswald, Greifswald, Germany.

The Lancet. Neurology
|December 14, 2022
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Investigating Migraine-Like Behavior Using Light Aversion in Mice
05:23

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

3.9K
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.3K

Related Experiment Videos

Last Updated: Aug 17, 2025

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

8.2K
Investigating Migraine-Like Behavior Using Light Aversion in Mice
05:23

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

3.9K
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.3K

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

720
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
720

Articles linked to this work by shared authors, journal, and citation graph.

Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial.

The Lancet. Neurology·2026

Efficacy, IHS Guideline Adherence, and Methodological Quality of Noninvasive Neuromodulation Clinical Trials in Migraine and Cluster Headache: A Systematic Review.

European journal of neurology·2026

Efficacy of a multidisciplinary 5-day headache day-clinic program: A prospective quasi-experimental pre-post study in primary headache disorders.

Headache·2026

What's a migraine day? Towards a consensus definition for clinical care and research - a Delphi panel-based study.

The journal of headache and pain·2026

Oxytocin receptor antagonism in migraine: a randomized, double-blind, placebo-controlled provocation study.

The journal of headache and pain·2026

Correction: Sex hormone profiles in men with migraine: a cross-sectional, matched cohort study.

Frontiers in neurology·2026

Deep brain stimulation for the treatment of patients with dystonia: advances towards network-based personalised care.

The Lancet. Neurology·2026

The role of the gut microbiome in mediating neuroinflammation in immune-based neurological disorders.

The Lancet. Neurology·2026

Parkinson's disease genetics across diverse ancestries: an observational genetic study of causal and risk variants with translational implications.

The Lancet. Neurology·2026

Survival estimates and their predictors in genetic frontotemporal dementia: an international, retrospective, cohort study.

The Lancet. Neurology·2026

Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial.

The Lancet. Neurology·2026

Global Health in Radiology: Evolution, Challenges, and a Framework for the Future.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2026

Regional Statistics from 2023 Community-based Severe Trauma Surveillance in the Gyeongnam Region.

Public health weekly report·2026

Knowing better, doing better: Taking stock of the UN Agenda 2030, its means, its progress, and its shortfalls.

iScience·2026

Mapping stakeholders' positioning in the access and delivery partnership value chain: the case of the RTS,S malaria vaccine introduction in Ghana.

International journal of public health·2026

Mapping immune responses to TAK-003 dengue vaccine: immunogenicity across the clinical development program.

Frontiers in immunology·2026

Resilience as recovery: stakeholder perspectives on Uganda's health system response to infectious disease shocks.

Frontiers in health services·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us